Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Delafloxacin manufacturers

4 products found

Filters

4 products found

delafloxacin

Solution for infusion 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Available for various territories in EU (not EU5), CEE, Russia, CIS, APAC
Manufacturer #33499
The company is a global leader in pharmaceuticals and diagnostics, with a presence in over 140 countries across regions including Europe, Asia, Africa, and North America. With a history of over 135 years, the company specializes in prescription medications and diagnostics, focusing on key therapy areas such as oncology, cardiology, pneumology, and gastroenterology. It operates 18 manufacturing sites, including a biotech plant for monoclonal antibodies, and nine R&D centers dedicated to developing innovative therapies, including small molecules and biologics for hematologic and solid tumors. The company maintains GMP certifications and invests in advanced diagnostic technologies.

Manufacturer usually replies in nan days

delafloxacin

Tablets 450 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Available for various territories in EU (not EU5), CEE, Russia, CIS, APAC
Manufacturer #33499
The company is a global leader in pharmaceuticals and diagnostics, with a presence in over 140 countries across regions including Europe, Asia, Africa, and North America. With a history of over 135 years, the company specializes in prescription medications and diagnostics, focusing on key therapy areas such as oncology, cardiology, pneumology, and gastroenterology. It operates 18 manufacturing sites, including a biotech plant for monoclonal antibodies, and nine R&D centers dedicated to developing innovative therapies, including small molecules and biologics for hematologic and solid tumors. The company maintains GMP certifications and invests in advanced diagnostic technologies.

Manufacturer usually replies in nan days

delafloxacin

Injection, lyophilized 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340
The company is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 8 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible